Related Experiment Videos
Biochemical modulation of cisplatin toxicity
Pharmacology & Therapeutics
|January 1, 1989
Summary
Biochemical modulation improves cisplatin chemotherapy safety by reducing kidney damage. However, higher doses cause new nervous system and bone marrow toxicities, requiring further research for optimal use and broader protection.
Area of Science:
- Oncology
- Pharmacology
- Biochemistry
Background:
- Biochemical modulation enhances cisplatin chemotherapy safety and efficacy.
- Established protocols successfully mitigate cisplatin-induced nephrotoxicity, making renal issues rare.
- Increased cisplatin doses, enabled by modulators, have led to new dose-limiting toxicities.
Purpose of the Study:
- To review the impact of biochemical modulation on cisplatin toxicity.
- To assess the success of current protocols in managing cisplatin-induced nephrotoxicity.
- To identify emerging toxicities and explore strategies for mitigating them.
Main Methods:
- Review of clinical data and research on biochemical modulators of cisplatin.
- Analysis of mechanisms underlying normal tissue protection.
- Evaluation of preliminary data on novel modulators and combination therapies.
Main Results:
- Cisplatin-induced nephrotoxicity is largely controlled by current modulators.
- New dose-limiting toxicities affect the nervous system and bone marrow.
- Preliminary evidence suggests certain modulators may reduce these new toxicities.
Conclusions:
- While nephrotoxicity is managed, new toxicities necessitate further clinical trials.
- Optimal scheduling and efficacy of newer agents require extensive investigation.
- Combination therapies, like DDTC and hypertonic saline, show promise for broad normal tissue protection and warrant further study.